![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » CANGENE ANNOUNCES FISCAL 2005 FINANCIAL RESULTS
CANGENE ANNOUNCES FISCAL 2005 FINANCIAL RESULTS
October 20, 2005
Cangene Corporation today reports financial results for the year ended July 31, 2005. Revenues for the year were $102.7 million, down $54.2 million or 35% from fiscal 2004. The decrease relates primarily to the completion of the Vaccinia immune globulin (VIG) contract with the U.S. government, which was ongoing in 2004 and generated $42.3 million in revenue last year compared with $3.5 million in total VIG sales in 2005.
Canada NewsWire (http://www.newswire.ca/en/releases/archive/October2005/19/c3460.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct